Kyongbo Pharmaceutical Co Ltd (214390) — Free Cash Flow Generation Index
Kyongbo Pharmaceutical Co Ltd (214390) has a Free Cash Flow Generation Index of -2.78x as of September 2025. Free cash flow of ₩-12.53 Billion represents -3% of operating cash flow (₩4.51 Billion). Read Kyongbo Pharmaceutical Co Ltd (214390) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Kyongbo Pharmaceutical Co Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Kyongbo Pharmaceutical Co Ltd across 10 annual periods. Explore 214390 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Kyongbo Pharmaceutical Co Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Kyongbo Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see how much is Kyongbo Pharmaceutical Co Ltd worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -87.35x | ₩-13.03 Billion | ₩149.12 Million | ₩13.18 Billion | ▼ -6914.5% |
| 2023 | -1.25x | ₩-6.03 Billion | ₩4.84 Billion | ₩10.88 Billion | ▼ -312.5% |
| 2022 | -0.30x | ₩-3.06 Billion | ₩10.13 Billion | ₩13.18 Billion | ▼ -1425.3% |
| 2021 | -0.02x | ₩-355.61 Million | ₩17.97 Billion | ₩18.32 Billion | ▼ -104.9% |
| 2020 | 0.40x | ₩8.36 Billion | ₩20.80 Billion | ₩12.44 Billion | ▲ +2154.5% |
| 2019 | 0.02x | ₩421.97 Million | ₩23.67 Billion | ₩23.25 Billion | ▼ -97.5% |
| 2017 | 0.71x | ₩18.41 Billion | ₩25.81 Billion | ₩7.40 Billion | ▲ +220.1% |
| 2016 | 0.22x | ₩5.64 Billion | ₩25.33 Billion | ₩19.68 Billion | ▲ +104.1% |
| 2015 | -5.43x | ₩-23.02 Billion | ₩4.24 Billion | ₩27.26 Billion | ▼ -2589.5% |
| 2014 | -0.20x | ₩-3.24 Billion | ₩16.04 Billion | ₩19.28 Billion | — |